Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Riezman Joshua | Director | 1 | $0 | $0 | 2025-08-08 |
| Wood Steven D | Director | 6 | $0 | $0 | 2025-07-15 |
| Flynn James P | Director | 6 | $0 | $0 | 2025-07-15 |
| File Justin J. | Secretary, Acting CEO & CFO | 1 | $0 | $0 | 2025-07-15 |
| Glover Nicholas | Director | 13 | $0 | $0 | 2025-07-15 |
| Reynolds Thomas C | Director | 14 | $16.0K | $0 | 2025-07-15 |
| DRISCOLL FREDERICK W | Director | 10 | $100.0K | $100.8K | 2025-07-15 |
| Funicular Funds, LP | 10% Owner | 3 | $0 | $0 | 2023-10-20 |
| Kassam Moez | 10% Owner | 7 | $938.3K | $0 | 2023-10-20 |
| Ma-Weaver Jacob | 10% Owner | 6 | $845.0K | $840 | 2023-10-11 |
| Anson Funds Management LP | 10% Owner | 4 | $0 | $0 | 2023-10-11 |
| Baltic Charles V. III | Director | 36 | $296.2K | $24.3K | 2023-09-29 |
| KANGO SUJAY | Director | 3 | $0 | $0 | 2023-09-29 |
| GOLD DANIEL P PHD | Director | 28 | $30.0K | $0 | 2023-09-29 |
| HOWSON TAMAR D | Director | 5 | $0 | $0 | 2023-09-29 |
| GHALIE RICHARD G | Chief Medical Officer | 5 | $0 | $0 | 2023-09-29 |
| Winson Bruce Ross | 10% Owner | 2 | $329.2K | $1.4K | 2023-09-22 |
| Urso David M | Sr. V.P. and General Counsel | 17 | $0 | $34.0K | 2023-06-02 |
| Cohen Cheryl | Director | 4 | $0 | $0 | 2022-07-05 |
| Drazba Brian G. | Chief Financial Officer | 9 | $20.0K | $0 | 2022-07-05 |
| White Christine Anna | Director | 13 | $26.1K | $0 | 2022-07-05 |
| Clemens Kevan | Director | 8 | $0 | $0 | 2021-07-01 |
| Mass Robert D. | Chief Medical Officer | 13 | $0 | $0 | 2020-07-02 |
| Rueckert William Dodge | Director | 14 | $0 | $0 | 2019-07-01 |
| Zech Thomas M. | Chief Financial Officer | 7 | $0 | $0 | 2016-08-05 |
| Cann Leah Rush | Director | 6 | $0 | $0 | 2016-07-29 |
| VIVO VENTURES VII, LLC | 10% Owner | 5 | $0 | $720.4K | 2015-11-09 |
| Vivo Ventures V, LLC | 10% Owner | 10 | $0 | $295.1K | 2015-11-09 |
| Delagardelle Jeani | 10% Owner | 2 | $0 | $6.17M | 2015-03-24 |
| HUNT RONALD | 10% Owner | 4 | $0 | $2.19M | 2014-12-09 |
| Vivo Ventures VII Affiliates Fund, L.P. | 10% Owner | 4 | $0 | $4.30M | 2013-10-29 |
| Vivo Ventures Fund VII, L.P. | 10% Owner | 4 | $0 | $6.13M | 2013-10-02 |
| Vivo Ventures Fund V, L.P. | 10% Owner | 2 | $0 | $343.5K | 2013-10-02 |
| Vivo Ventures V Affiliates Fund, L.P. | 10% Owner | 1 | $0 | $9.2K | 2013-05-16 |
| New Leaf Ventures II, L.P. | 10% Owner | 2 | $0 | $2.18M | 2013-04-19 |
| NIEDEL JAMES | 10% Owner | 2 | $0 | $3.34M | 2013-02-19 |
| AUSTIN JOSIAH T | 10% Owner | 1 | $0 | $0 | 2012-12-06 |
| El Coronado Holdings, LLC | 10% Owner | 1 | $0 | $0 | 2012-12-03 |
| NOVOGEN LTD | 10% Owner | 3 | $0 | $0 | 2012-12-03 |
| Williams Bryan | Director | 1 | $0 | $0 | 2012-09-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Riezman Joshua | Director | A Award deriv | 2025-08-08 | 2025-08-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| File Justin J. | Secretary, Acting CEO & CFO | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Flynn James P | Director | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wood Steven D | Director | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wood Steven D | Director | A Award | 2024-05-17 | 2024-05-21 | 3,100 | $3.17 | $9.8K | 4,359 | SEC↗ |
| Flynn James P | Director | A Award | 2024-05-16 | 2024-05-20 | 7,900 | $3.16 | $25.0K | 7,900 | SEC↗ |
| Wood Steven D | Director | A Award deriv | 2023-12-18 | 2024-01-12 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Wood Steven D | Director | A Award deriv | 2023-12-18 | 2024-01-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Flynn James P | Director | A Award deriv | 2023-12-18 | 2024-01-12 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Flynn James P | Director | A Award deriv | 2023-12-18 | 2024-01-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Flynn James P | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Flynn James P | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Wood Steven D | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Wood Steven D | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kassam Moez | 10% Owner | X Exercise deriv | 2023-10-20 | 2023-10-24 | 1,432 | — | $0 | 7,068 | SEC↗ |
| Kassam Moez | 10% Owner | X Exercise deriv | 2023-10-20 | 2023-10-24 | 358 | — | $0 | 6,710 | SEC↗ |
| Kassam Moez | 10% Owner | E Expire deriv | 2023-10-20 | 2023-10-24 | 6,710 | — | $0 | 0 | SEC↗ |
| Funicular Funds, LP | 10% Owner | X Exercise deriv | 2023-10-20 | 2023-10-24 | 1,206 | — | $0 | 4,494 | SEC↗ |
| Funicular Funds, LP | 10% Owner | E Expire deriv | 2023-10-20 | 2023-10-24 | 4,494 | — | $0 | 0 | SEC↗ |
| Kassam Moez | 10% Owner | X Exercise | 2023-10-20 | 2023-10-24 | 143,200 | $7.00 | $1.00M | 1,057,388 | SEC↗ |
| Kassam Moez | 10% Owner | X Exercise | 2023-10-20 | 2023-10-24 | 35,800 | $7.00 | $250.6K | 1,093,188 | SEC↗ |
| Funicular Funds, LP | 10% Owner | X Exercise | 2023-10-20 | 2023-10-24 | 120,600 | $7.00 | $844.2K | 611,440 | SEC↗ |
| Anson Funds Management LP | 10% Owner | X Exercise deriv | 2023-10-11 | 2023-10-13 | 100 | — | $0 | 8,500 | SEC↗ |
| Anson Funds Management LP | 10% Owner | X Exercise deriv | 2023-10-11 | 2023-10-13 | 400 | — | $0 | 8,600 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | X Exercise deriv | 2023-10-11 | 2023-10-13 | 300 | — | $0 | 5,700 | SEC↗ |
| Anson Funds Management LP | 10% Owner | X Exercise | 2023-10-11 | 2023-10-13 | 10,000 | $7.00 | $70.0K | 914,188 | SEC↗ |
| Anson Funds Management LP | 10% Owner | X Exercise | 2023-10-11 | 2023-10-13 | 40,000 | $7.00 | $280.0K | 904,188 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | X Exercise | 2023-10-11 | 2023-10-13 | 30,000 | $7.00 | $210.0K | 490,840 | SEC↗ |
| GHALIE RICHARD G | Chief Medical Officer | A Award deriv | 2023-09-29 | 2023-10-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KANGO SUJAY | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GOLD DANIEL P PHD | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | S Sale deriv | 2023-09-22 | 2023-09-25 | 6,000 | $0.14 | $840 | 6,000 | SEC↗ |
| Winson Bruce Ross | 10% Owner | S Sale deriv | 2023-09-22 | 2023-09-25 | 9,000 | $0.15 | $1.4K | 9,000 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | P Buy | 2023-09-22 | 2023-09-25 | 32,040 | $6.85 | $219.5K | 460,840 | SEC↗ |
| Winson Bruce Ross | 10% Owner | P Buy | 2023-09-22 | 2023-09-25 | 48,060 | $6.85 | $329.2K | 864,188 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | P Buy | 2023-09-21 | 2023-09-22 | 22,400 | $6.46 | $144.7K | 428,800 | SEC↗ |
| Kassam Moez | 10% Owner | P Buy | 2023-09-21 | 2023-09-22 | 33,600 | $6.46 | $217.1K | 816,128 | SEC↗ |
| Ma-Weaver Jacob | 10% Owner | P Buy | 2023-09-20 | 2023-09-22 | 80,000 | $6.01 | $480.8K | 406,400 | SEC↗ |
| Kassam Moez | 10% Owner | P Buy | 2023-09-20 | 2023-09-22 | 120,000 | $6.01 | $721.2K | 782,528 | SEC↗ |
| Urso David M | President and CEO | A Award deriv | 2023-06-02 | 2023-06-06 | 166,571 | — | $0 | 166,571 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2023-02-28 | 2023-03-01 | 81,500 | $0.23 | $18.7K | 105,750 | SEC↗ |
| GHALIE RICHARD G | Chief Medical Officer | A Award deriv | 2022-07-05 | 2022-07-07 | 560,000 | — | $0 | 560,000 | SEC↗ |
| KANGO SUJAY | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award deriv | 2022-07-05 | 2022-07-07 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2022-07-05 | 2022-07-07 | 350,000 | — | $0 | 350,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2022-07-05 | 2022-07-07 | 1,496,000 | — | $0 | 1,496,000 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 88 | — | $0 | 87,500 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| GHALIE RICHARD G | Chief Medical Officer | F Tax w/h | 2022-07-05 | 2022-07-07 | 8,196 | $0.54 | $4.4K | 28,927 | SEC↗ |
| KANGO SUJAY | Director | A Award deriv | 2021-11-22 | 2021-11-23 | 58,334 | — | $0 | 58,334 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | F Tax w/h | 2021-07-02 | 2021-07-06 | 41,320 | $2.94 | $121.5K | 417,312 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | F Tax w/h | 2021-07-02 | 2021-07-06 | 24,825 | $2.94 | $73.0K | 49,281 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2021-07-01 | 2021-07-06 | 855,000 | — | $0 | 855,000 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award deriv | 2021-07-01 | 2021-07-06 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2021-07-01 | 2021-07-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GHALIE RICHARD G | Chief Medical Officer | A Award deriv | 2021-07-01 | 2021-07-06 | 320,000 | — | $0 | 320,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise deriv | 2021-05-25 | 2021-05-27 | 5,000 | — | $0 | 675,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise | 2021-05-25 | 2021-05-27 | 5,000 | $2.52 | $12.6K | 458,632 | SEC↗ |
| GHALIE RICHARD G | Chief Medical Officer | A Award deriv | 2021-05-03 | 2021-05-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | S Sale | 2021-02-23 | 2021-02-24 | 25,000 | $4.03 | $100.8K | 37,500 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise deriv | 2020-07-23 | 2020-07-27 | 12,000 | — | $0 | 275,500 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise | 2020-07-23 | 2020-07-27 | 12,000 | $1.57 | $18.8K | 453,632 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2020-07-02 | 2020-07-07 | 680,000 | — | $0 | 680,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2020-07-02 | 2020-07-07 | 230,000 | — | $0 | 230,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2020-07-02 | 2020-07-07 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award deriv | 2020-07-02 | 2020-07-07 | 525,000 | — | $0 | 525,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award | 2020-07-02 | 2020-07-07 | 80,000 | — | $0 | 441,632 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 74,106 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2020-04-10 | 2020-04-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | P Buy | 2019-12-19 | 2019-12-20 | 18,750 | $1.60 | $30.0K | 361,632 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | P Buy | 2019-12-19 | 2019-12-20 | 12,500 | $1.60 | $20.0K | 37,500 | SEC↗ |
| DRISCOLL FREDERICK W | Director | P Buy | 2019-12-19 | 2019-12-20 | 62,500 | $1.60 | $100.0K | 62,500 | SEC↗ |
| Reynolds Thomas C | Director | P Buy | 2019-12-19 | 2019-12-20 | 10,000 | $1.60 | $16.0K | 10,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise deriv | 2019-09-27 | 2019-10-01 | 20,000 | — | $0 | 287,500 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | M Exercise | 2019-09-27 | 2019-10-01 | 20,000 | $1.57 | $31.4K | 342,882 | SEC↗ |
| White Christine Anna | Director | P Buy | 2019-09-06 | 2019-09-09 | 15,000 | $1.74 | $26.1K | 15,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2019-07-01 | 2019-07-03 | 230,000 | — | $0 | 230,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2019-07-01 | 2019-07-03 | 680,000 | — | $0 | 680,000 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2019-07-01 | 2019-07-03 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award deriv | 2019-07-01 | 2019-07-03 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | S Sale | 2018-08-07 | 2018-08-08 | 9,500 | $3.58 | $34.0K | 24,106 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | F Tax w/h | 2018-08-06 | 2018-08-08 | 54,093 | $3.75 | $202.8K | 319,727 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | F Tax w/h | 2018-08-06 | 2018-08-08 | 17,709 | $3.75 | $66.4K | 33,661 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | F Tax w/h | 2018-08-06 | 2018-08-08 | 17,764 | $3.75 | $66.6K | 33,606 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | F Tax w/h | 2018-08-06 | 2018-09-06 | 50,938 | $3.75 | $191.0K | 322,882 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2018-07-12 | 2018-07-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2018-07-12 | 2018-07-16 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2018-07-12 | 2018-07-16 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Urso David M | Chief Operating Officer & GC | A Award deriv | 2018-07-12 | 2018-07-16 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2018-06-22 | 2018-06-26 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2018-06-22 | 2018-06-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2018-06-22 | 2018-06-26 | 380,000 | — | $0 | 380,000 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2018-06-22 | 2018-06-26 | 130,000 | — | $0 | 130,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | F Tax w/h | 2018-03-29 | 2018-03-30 | 128,920 | $2.07 | $266.9K | 271,080 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2018-02-22 | 2018-02-26 | 33,333 | — | $0 | 33,333 | SEC↗ |
| Baltic Charles V. III | Director | S Sale | 2017-11-27 | 2017-11-29 | 11,000 | $2.21 | $24.3K | 13,250 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2017-11-27 | 2017-11-29 | 11,000 | $2.25 | $24.8K | 24,250 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2017-07-06 | 2017-07-10 | 50,000 | — | $0 | 200,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2017-07-06 | 2017-07-10 | 380,000 | — | $0 | 1,234,166 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2017-07-06 | 2017-07-10 | 135,000 | — | $0 | 555,556 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2017-07-06 | 2017-07-10 | 130,000 | — | $0 | 537,500 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 122,730 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 112,667 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 118,793 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 121,049 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 122,730 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2017-07-06 | 2017-07-10 | 40,000 | — | $0 | 122,730 | SEC↗ |
| Drazba Brian G. | Chief Financial Officer | A Award deriv | 2017-04-03 | 2017-04-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2016-08-05 | 2016-08-09 | 17,123 | — | $0 | 17,123 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2016-08-05 | 2016-08-09 | 51,370 | — | $0 | 51,370 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2016-08-05 | 2016-08-09 | 51,370 | — | $0 | 51,370 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2016-08-05 | 2016-08-09 | 102,740 | — | $0 | 102,740 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2016-07-29 | 2016-08-01 | 110,000 | — | $0 | 338,757 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 86,924 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 86,924 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 72,667 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 78,793 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2016-07-29 | 2016-08-01 | 380,000 | — | $0 | 870,832 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2016-07-29 | 2016-08-01 | 135,000 | — | $0 | 420,556 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 81,049 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 86,924 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2016-07-29 | 2016-08-01 | 130,000 | — | $0 | 407,500 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2016-07-29 | 2016-08-01 | 40,000 | — | $0 | 86,924 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2015-11-09 | 2015-11-09 | 9,142 | $1.75 | $16.0K | 183,767 | SEC↗ |
| VIVO VENTURES VII, LLC | 10% Owner | S Sale | 2015-11-09 | 2015-11-09 | 157,352 | $1.75 | $275.4K | 3,163,105 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2015-11-06 | 2015-11-09 | 440 | $1.85 | $814 | 192,909 | SEC↗ |
| VIVO VENTURES VII, LLC | 10% Owner | S Sale | 2015-11-06 | 2015-11-09 | 7,560 | $1.85 | $14.0K | 3,320,457 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2015-11-05 | 2015-11-09 | 13,111 | $1.91 | $25.0K | 193,349 | SEC↗ |
| VIVO VENTURES VII, LLC | 10% Owner | S Sale | 2015-11-05 | 2015-11-09 | 225,660 | $1.91 | $431.0K | 3,328,017 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2015-07-28 | 2015-07-29 | 90,000 | — | $0 | 228,757 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 46,924 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 46,924 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 32,667 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 38,793 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2015-07-28 | 2015-07-29 | 307,500 | — | $0 | 490,832 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2015-07-28 | 2015-07-29 | 112,500 | — | $0 | 315,159 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 41,049 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 46,924 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2015-07-28 | 2015-07-29 | 127,500 | — | $0 | 277,500 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2015-07-28 | 2015-07-29 | 20,000 | — | $0 | 46,924 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | O Exercise OTM deriv | 2015-03-24 | 2015-03-26 | 24,401 | — | $0 | 0 | SEC↗ |
| VIVO VENTURES VII, LLC | 10% Owner | O Exercise OTM deriv | 2015-03-24 | 2015-03-26 | 420,000 | — | $0 | 0 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | O Exercise OTM | 2015-03-24 | 2015-03-26 | 26,445 | $3.12 | $82.5K | 206,460 | SEC↗ |
| VIVO VENTURES VII, LLC | 10% Owner | O Exercise OTM | 2015-03-24 | 2015-03-26 | 455,174 | $3.12 | $1.42M | 3,553,677 | SEC↗ |
| Delagardelle Jeani | 10% Owner | S Sale | 2015-03-24 | 2015-03-26 | 1,601,390 | $1.97 | $3.15M | 0 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2015-01-21 | 2015-01-23 | 5,000 | $3.81 | $19.1K | 24,250 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2014-12-31 | 2015-01-02 | 1,500 | $4.26 | $6.4K | 5,350 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2014-12-31 | 2015-01-02 | 1,500 | $4.28 | $6.4K | 19,250 | SEC↗ |
| HUNT RONALD | 10% Owner | S Sale | 2014-12-09 | 2014-12-10 | 70,081 | $6.01 | $421.2K | 1,601,390 | SEC↗ |
| HUNT RONALD | 10% Owner | S Sale | 2014-12-08 | 2014-12-10 | 9,004 | $6.05 | $54.5K | 1,671,471 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2014-12-03 | 2014-12-05 | 12,667 | — | $0 | 12,667 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 18,793 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 26,924 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 21,049 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 26,924 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2014-07-14 | 2014-07-16 | 32,000 | — | $0 | 202,659 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2014-07-14 | 2014-07-16 | 100,000 | — | $0 | 220,062 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 26,924 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2014-07-14 | 2014-07-16 | 30,000 | — | $0 | 150,000 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2014-07-14 | 2014-07-16 | 30,000 | — | $0 | 151,000 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2014-07-14 | 2014-07-16 | 8,000 | — | $0 | 26,924 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2014-06-30 | 2014-07-02 | 950 | $6.60 | $6.3K | 3,850 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2014-06-30 | 2014-07-02 | 1,050 | $6.52 | $6.8K | 17,750 | SEC↗ |
| Urso David M | Sr. V.P. and General Counsel | A Award deriv | 2014-04-07 | 2014-04-08 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Delagardelle Jeani | 10% Owner | S Sale | 2013-11-21 | 2013-11-25 | 365,000 | $8.25 | $3.01M | 1,680,475 | SEC↗ |
| Vivo Ventures VII Affiliates F | 10% Owner | S Sale | 2013-10-29 | 2013-10-29 | 756 | $8.27 | $6.3K | 3,098,503 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2013-10-29 | 2013-10-29 | 44 | $8.27 | $364 | 180,015 | SEC↗ |
| Vivo Ventures VII Affiliates F | 10% Owner | S Sale | 2013-10-28 | 2013-10-29 | 38,953 | $8.30 | $323.3K | 3,099,259 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2013-10-28 | 2013-10-29 | 2,263 | $8.30 | $18.8K | 180,059 | SEC↗ |
| Vivo Ventures VII Affiliates F | 10% Owner | S Sale | 2013-10-25 | 2013-10-29 | 259,900 | $8.20 | $2.13M | 3,138,212 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2013-10-25 | 2013-10-29 | 15,100 | $8.20 | $123.8K | 182,322 | SEC↗ |
| Vivo Ventures Fund VII, L.P. | 10% Owner | S Sale | 2013-10-02 | 2013-10-03 | 486,107 | $10.00 | $4.86M | 3,398,112 | SEC↗ |
| Vivo Ventures Fund V, L.P. | 10% Owner | S Sale | 2013-10-02 | 2013-10-03 | 28,243 | $10.00 | $282.4K | 197,422 | SEC↗ |
| Vivo Ventures Fund VII, L.P. | 10% Owner | S Sale | 2013-10-01 | 2013-10-03 | 95,539 | $11.00 | $1.05M | 3,884,219 | SEC↗ |
| Vivo Ventures Fund V, L.P. | 10% Owner | S Sale | 2013-10-01 | 2013-10-03 | 5,551 | $11.00 | $61.1K | 225,665 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-08-16 | 2013-08-20 | 1,400 | $6.82 | $9.5K | 16,700 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-08-16 | 2013-08-20 | 1,200 | $6.82 | $8.2K | 2,900 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 10,793 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 18,924 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 18,924 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 18,924 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2013-07-15 | 2013-07-17 | 10,000 | — | $0 | 121,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 18,924 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2013-07-15 | 2013-07-17 | 34,000 | — | $0 | 170,659 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2013-07-15 | 2013-07-17 | 6,730 | — | $0 | 13,049 | SEC↗ |
| Vivo Ventures Fund VII, L.P. | 10% Owner | S Sale | 2013-06-28 | 2013-07-02 | 7,337 | $7.58 | $55.6K | 3,979,758 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2013-06-28 | 2013-07-02 | 426 | $7.58 | $3.2K | 231,216 | SEC↗ |
| Vivo Ventures V, LLC | 10% Owner | S Sale | 2013-06-11 | 2013-06-13 | 13,727 | $7.80 | $107.1K | 231,642 | SEC↗ |
| Vivo Ventures VII Affiliates F | 10% Owner | S Sale | 2013-06-11 | 2013-06-13 | 236,273 | $7.80 | $1.84M | 3,987,095 | SEC↗ |
| Glover Nicholas | Director | A Award deriv | 2013-06-07 | 2013-06-11 | 4,063 | — | $0 | 4,063 | SEC↗ |
| Vivo Ventures Fund VII, L.P. | 10% Owner | S Sale | 2013-05-16 | 2013-05-20 | 17,428 | $9.07 | $158.1K | 4,223,368 | SEC↗ |
| Vivo Ventures V Affiliates Fun | 10% Owner | S Sale | 2013-05-16 | 2013-05-20 | 1,012 | $9.07 | $9.2K | 245,369 | SEC↗ |
| HUNT RONALD | 10% Owner | S Sale | 2013-05-08 | 2013-05-08 | 100,000 | $8.45 | $845.0K | 2,045,475 | SEC↗ |
| HUNT RONALD | 10% Owner | S Sale | 2013-05-06 | 2013-05-08 | 100,000 | $8.70 | $870.0K | 2,145,475 | SEC↗ |
| New Leaf Ventures II, L.P. | 10% Owner | S Sale | 2013-04-19 | 2013-04-22 | 157,300 | $8.43 | $1.33M | 2,245,475 | SEC↗ |
| New Leaf Ventures II, L.P. | 10% Owner | S Sale | 2013-04-18 | 2013-04-22 | 100,000 | $8.57 | $857.0K | 2,402,775 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2013-03-29 | 2013-04-02 | 81,835 | — | $0 | 111,000 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2013-03-29 | 2013-04-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2013-03-29 | 2013-04-02 | 4,032 | — | $0 | 12,194 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2013-03-29 | 2013-04-02 | 4,032 | — | $0 | 12,194 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2013-03-29 | 2013-04-02 | 68,330 | — | $0 | 136,659 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2013-03-29 | 2013-04-02 | 4,032 | — | $0 | 12,194 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2013-03-29 | 2013-04-02 | 4,032 | — | $0 | 12,194 | SEC↗ |
| NIEDEL JAMES | 10% Owner | S Sale | 2013-02-19 | 2013-02-20 | 300,000 | $6.80 | $2.04M | 2,502,775 | SEC↗ |
| NIEDEL JAMES | 10% Owner | S Sale | 2013-02-15 | 2013-02-20 | 197,225 | $6.60 | $1.30M | 2,802,775 | SEC↗ |
| Reynolds Thomas C | Director | A Award deriv | 2013-02-07 | 2013-02-11 | 6,319 | — | $0 | 6,319 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-08-20 | 4,200 | $6.25 | $26.3K | 9,300 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-08-20 | 80 | $5.75 | $460 | 9,380 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-08-20 | 5,920 | $5.90 | $34.9K | 15,300 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-01-29 | 5,920 | $5.90 | $34.9K | 17,000 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-01-29 | 80 | $5.75 | $460 | 11,080 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-25 | 2013-01-29 | 4,200 | $6.25 | $26.3K | 11,000 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-24 | 2013-08-20 | 800 | $6.25 | $5.0K | 5,100 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2013-01-24 | 2013-01-28 | 800 | $6.25 | $5.0K | 6,800 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2012-12-21 | 2013-08-20 | 1,800 | $7.19 | $12.9K | 4,300 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2012-12-21 | 2013-08-20 | 1,700 | $7.17 | $12.2K | 1,700 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2012-12-21 | 2012-12-26 | 1,700 | $7.17 | $12.2K | 6,000 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2012-12-21 | 2012-12-26 | 1,800 | $7.19 | $12.9K | 4,300 | SEC↗ |
| Rueckert William Dodge | Director | J Other deriv | 2012-12-06 | 2013-09-12 | 2,988,672 | — | $0 | 2,991,506 | SEC↗ |
| Rueckert William Dodge | Director | J Other deriv | 2012-12-06 | 2012-12-10 | 2,988,672 | — | $0 | 2,989,380 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | J Other deriv | 2012-12-06 | 2012-12-11 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| NOVOGEN LTD | 10% Owner | J Other | 2012-12-03 | 2012-12-05 | 17,837,246 | — | $0 | 0 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | J Other | 2012-12-03 | 2012-12-05 | 3,478,245 | — | $0 | 3,832,081 | SEC↗ |
| NOVOGEN LTD | 10% Owner | C Conversion deriv | 2012-11-20 | 2012-11-21 | 1,000 | — | $0 | 0 | SEC↗ |
| NOVOGEN LTD | 10% Owner | C Conversion | 2012-11-20 | 2012-11-21 | 4,827,000 | — | $0 | 17,837,246 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2012-11-16 | 2012-11-20 | 300,000 | — | $0 | 720,390 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2012-11-16 | 2012-11-20 | 300,000 | — | $0 | 720,390 | SEC↗ |
| Williams Bryan | Director | A Award deriv | 2012-09-21 | 2012-09-25 | 23,810 | — | $0 | 48,979 | SEC↗ |
| White Christine Anna | Director | A Award deriv | 2012-09-21 | 2012-09-25 | 23,810 | — | $0 | 48,979 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2012-09-21 | 2012-09-25 | 23,810 | — | $0 | 48,979 | SEC↗ |
| Baltic Charles V. III | Director | A Award deriv | 2012-09-21 | 2012-09-25 | 23,810 | — | $0 | 48,979 | SEC↗ |
| Cann Leah Rush | Director | A Award deriv | 2012-09-21 | 2012-09-25 | 23,810 | — | $0 | 48,979 | SEC↗ |
| Zech Thomas M. | Chief Financial Officer | A Award deriv | 2012-08-07 | 2012-08-09 | 75,000 | — | $0 | 175,000 | SEC↗ |
| Mass Robert D. | Chief Medical Officer | A Award deriv | 2012-08-07 | 2012-08-09 | 232,359 | — | $0 | 409,979 | SEC↗ |
| GOLD DANIEL P PHD | Chief Executive Officer | A Award deriv | 2012-08-07 | 2012-08-09 | 100,000 | — | $0 | 420,390 | SEC↗ |
| Baltic Charles V. III | Director | P Buy | 2012-07-05 | 2012-07-09 | 15,000 | $0.43 | $6.5K | 15,000 | SEC↗ |
| Rueckert William Dodge | Director | X Exercise deriv | 2012-05-11 | 2013-09-12 | 2,834 | $7.14 | $20.2K | 2,834 | SEC↗ |
| Rueckert William Dodge | Director | X Exercise deriv | 2012-05-11 | 2013-09-12 | 2,834 | — | $0 | 0 | SEC↗ |
| Rueckert William Dodge | Director | X Exercise | 2012-05-11 | 2013-09-12 | 236 | $5.34 | $1.3K | 654 | SEC↗ |